Mitigating the effects of nonadherence in clinical trials

Chairs: T Shiovitz, E Bain

At this session we will present findings of the ISCTM Nonadherence Workgroup in advance of (or in close proximity to) publication of the ISCTM white paper. At the conclusion of the conference, attendees will be able to identify types of nonadherence (NA), how nonadherence can adversely affect study outcome (including effects on sample and effect sizes), where/how to take action in order to ameliorate the negative effects of nonadherence on study success as well as regulatory issues related to eliminating or censoring non-adherent subjects.